Eczema Trial, Recruiting NCT07259343 Sponsor: Universidad Autónoma de Aguascalientes Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT07259343
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are between 2 and 12 years old
  • Children who have been diagnosed with atopic dermatitis (eczema) based on a specific set of medical criteria called the Hanifin and Rajka criteria
  • Children whose eczema is classified as mild, based on a scoring system called SCORAD showing a score below 25 points
  • A parent or legal guardian must have signed a written consent form agreeing for the child to take part

Who may not be able to join:

  • Children who are younger than 2 years old or older than 12 years old
  • Children whose eczema is moderate or severe, based on a SCORAD score above 25 points
  • Children who have other skin conditions alongside their eczema
  • Children who have previously had a serious allergic reaction, including anaphylaxis, to any ingredient in the cream being used in the trial
  • Children who have a known allergy or sensitivity to a substance called glycomacropeptide
  • Children who would not be able to attend follow-up appointments or stick to the treatment schedule as required
  • Children who the trial doctor considers unsuitable for the study for any other medical reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Eva M Salinas, PhD, Universidad Autónoma de Aguascalientes

Phone: 52 449-910-8424

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universidad Autónoma de Aguascalientes
Registry
ClinicalTrials.gov
Start date
26 September 2025
Est. completion
31 January 2026

Where this trial is recruiting

🇲🇽 Mexico

Primary endpoints

Change in SCORAD index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov